Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANEB-001 for Acute Cannabinoid Intoxication
NCT05282797Phase 2Completed
- Sponsor
- Anebulo Pharmaceuticals
- Start
- Dec 2021
- Primary completion
- Aug 2023
- Countries
- 1
01
Overview
A Phase 2 trial of drinabant in Acute cannabinoid intoxication (ACI), sponsored by Anebulo Pharmaceuticals. Started Dec 2021; status: completed.
02
Drugs
drinabant
03
Conditions
Acute cannabinoid intoxication (ACI)
Beyond the preview
Go deeper on NCT05282797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05282797.